Tealwood Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Tealwood Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	3,492 +3	+0.1%	+$1.33K	0.67%	73
2026 Q1	$1.56M	Buy	3,489 +27	+0.8%	+$12.6K	0.71%	75
2025 Q4	$1.57M	Sell	3,462 -21	-0.6%	-$9.05K	0.7%	75
2025 Q3	$1.36M	Buy	3,483 +17	+0.5%	+$7.11K	0.55%	94
2025 Q2	$1.54M	Sell	3,466 -83	-2%	-$38.2K	0.69%	71
2025 Q1	$1.72M	Sell	3,549 -41	-1%	-$19.1K	0.8%	54
2024 Q4	$1.45M	Sell	3,590 -23	-0.6%	-$10.7K	0.6%	79
2024 Q3	$1.68M	Buy	+3,613	New	+$1.74M	0.74%	61
2024 Q2	–	Sell	-4,379	Closed	-$1.83M	–	127
2024 Q1	$1.83M	Buy	4,379 +2	+0%	+$845	0.82%	47
2023 Q4	$1.78M	Sell	4,377 -92	-2%	-$34K	0.85%	43
2023 Q3	$1.55M	Buy	4,469 +76	+2%	+$26.6K	0.8%	49
2023 Q2	$1.55M	Buy	4,393 +9	+0.2%	+$3.03K	0.75%	53
2023 Q1	$1.38M	Sell	4,384 -118	-3%	-$35.4K	0.7%	58
2022 Q4	$1.3M	Sell	4,502 -67	-1%	-$20.4K	0.68%	68
2022 Q3	$1.32M	Sell	4,569 -8,806	-66%	-$2.53M	0.71%	54
2022 Q2	$3.77M	Sell	13,375 -627	-4%	-$168K	1.87%	3
2022 Q1	$3.65M	Sell	14,002 -295	-2%	-$70K	1.55%	5
2021 Q4	$3.14M	Sell	14,297 -595	-4%	-$116K	1.26%	11
2021 Q3	$2.7M	Buy	+14,892	New	+$2.91M	1.09%	21
2021 Q1	$2.61M	Buy	12,138 +6,103	+101%	+$1.34M	1.04%	29
2020 Q4	$1.43M	Buy	6,035 +2,467	+69%	+$566K	0.67%	56
2020 Q3	$971K	Buy	3,568 +1	+0%	+$276	0.63%	68
2020 Q2	$1.04M	Buy	+3,567	New	+$967K	0.69%	57

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Tealwood Asset Management's VRTX Position: Q2 2026 in Review

Tealwood Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.09% in Q2 2026, buying an estimated $1.33K and bringing the position to 3,492 shares worth $1.74M. The position accounts for 0.67% of the portfolio, ranked #73.

Tealwood Asset Management first reported a position in VRTX in Q2 2020 and has held it in 23 quarters since. The position peaked at $3.77M in Q2 2022. 355 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Tealwood Asset Management held 3,492 shares of Vertex Pharmaceuticals worth $1.74M as of Q2 2026.
Tealwood Asset Management bought 3 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.33K.
Vertex Pharmaceuticals made up 0.67% of Tealwood Asset Management's portfolio in Q2 2026, its #73 holding.
Tealwood Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 23 quarters since.
Tealwood Asset Management's Vertex Pharmaceuticals position peaked at $3.77M in Q2 2022.
355 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Tealwood Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.